Strategic Line 3 is entitled “Detection, Diagnostics, Monitoring and Prognostics of Diseases”. This line fosters innovative research to advance the identification of personalised biomarkers, essential both for early diagnosis and for predicting disease progression and individual response to treatment.

This research is relevant for transforming current diagnostics and optimising the efficacy of treatments for various pathologies.

To strengthen these lines of work, collaboration with hospital clinical services at regional and national level is encouraged, as well as the development of new industrial initiatives. Its promotion will contribute significantly to the creation of a new Clinical Trial Support Service, consolidating the link between research and clinical practice.

Research Groups

Within the line dedicated to the Detection, Diagnosis, Monitoring and Prognosis of Diseases, we can find the following associated research groups: